Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

BACKGROUND: This phase 3 study evaluated the efficacy of new adjuvant chemotherapy (MFP), which intensified the mitomycin-C (MMC) plus short-term doxifluridine (Mf) for gastric cancer. PATIENTS AND METHODS: A total of 855 patients (424 in Mf, 431 in MFP) with pathological stage II–IV (M0) gastric ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Y-K, Chang, H-M, Yook, J H, Ryu, M-H, Park, I, Min, Y J, Zang, D Y, Kim, G Y, Yang, D H, Jang, S J, Park, Y S, Lee, J-L, Kim, T W, Oh, S T, Park, B K, Jung, H-Y, Kim, B S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619263/
https://www.ncbi.nlm.nih.gov/pubmed/23449357
http://dx.doi.org/10.1038/bjc.2013.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619263/
https://www.ncbi.nlm.nih.gov/pubmed/23449357
http://dx.doi.org/10.1038/bjc.2013.86

Ejemplares similares